Basics Harvard Bioscience, Inc. Harvard Bioscience Inc is a developer, manufacturer and marketer of scientific instruments, systems and lab consumables used to advance life science for basic research, drug discovery, clinical and environmental testing. IPO Date: April 1, 2001 Sector: Healthcare Industry: Life Sciences Tools and Services Market Cap: $17.64M Activated in VL: True Average Daily Range Avg Daily Range: $0.10 | 2.53% Avg Daily Range (30 D): $0.03 | 6.34% Avg Daily Range (90 D): $0.03 | 7.48% Institutional Daily Volume Avg Daily Volume: .2M Avg Daily Volume (30 D): 1.42M Avg Daily Volume (90 D): 6.14M Trade Size Avg Trade Size (Sh.): 268 Avg Trade Size (Sh.) (30 D): 524 Avg Trade Size (Sh.) (90 D): 656 Institutional Trades Total Inst.Trades: 159 Avg Inst. Trade: $1.67M Avg Inst. Trade (30 D): $1.22M Avg Inst. Trade (90 D): $.96M Avg Inst. Trade Volume: .43M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $5.84M Avg Closing Trade (30 D): $1.22M Avg Closing Trade (90 D): $1.22M Avg Closing Volume: 1.52M     News Jun 2, 2025 @ 8:57 PM Harvard Bioscience Appoints John Duke to Board of ... Source: N/A May 12, 2025 @ 11:00 AM Harvard Bioscience Announces First Quarter 2025 Fi... Source: N/A Apr 10, 2025 @ 8:45 PM Harvard Bioscience Announces CFO Transition Source: N/A Mar 12, 2025 @ 8:00 PM Harvard Bioscience, Inc. to Participate in Two ... Source: N/A Feb 24, 2025 @ 4:00 PM Harvard Bioscience Schedules Fourth Quarter 2024 E... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.31 $-1.14 $.01 Diluted EPS $-1.31 $-1.14 $.01 Revenue $ 91.4M $ 21.77M $ 24.56M Gross Profit $ 52.18M $ 12.18M $ 14.01M Net Income / Loss $ -58.05M $ -50.34M $ .02M Operating Income / Loss $ -53.6M $ -49.67M $ .01M Cost of Revenue $ 39.22M $ 9.59M $ 10.55M Net Cash Flow $ .94M $ 1.1M $ -.1M PE Ratio